Prosecution Insights
Last updated: October 02, 2026
Application No. 18/068,858

ANTISENSE FINGERLOOP DNAS AND USES THEREOF

Non-Final OA §102
Filed
Dec 20, 2022
Priority
Jul 18, 2017 — provisional 62/533,857 +3 more
Examiner
LU, FRANK WEI MIN
Art Unit
1683
Tech Center
1600 — Biotechnology & Organic Chemistry
Assignee
The Ohio State University
OA Round
1 (Non-Final)
63%
Grant Probability
Moderate
1-2
OA Rounds
4m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 63% of resolved cases
63%
Career Allowance Rate
446 granted / 711 resolved
+2.7% vs TC avg
Strong +68% interview lift
Without
With
+67.7%
Interview Lift
resolved cases with interview
Typical timeline
4y 1m
Avg Prosecution
46 currently pending
Career history
771
Total Applications
across all art units

Statute-Specific Performance

§101
2.3%
-37.7% vs TC avg
§103
24.2%
-15.8% vs TC avg
§102
11.4%
-28.6% vs TC avg
§112
52.8%
+12.8% vs TC avg
Black line = Tech Center average estimate • Based on career data from 711 resolved cases

Office Action

§102
DETAILED ACTION Election/Restrictions Applicant’s election without traverse of species 1 (the detection probe is capable of hybridizing to an RNA target molecule, see claim 4) and species 4 (the one strand of the stem loop is an ascending strand of the stem loop, see claim 7) in the reply filed on July 6, 2026 is acknowledged. Claims 1, 2, 4, and 7-9 will be examined. Specification The substituted specification filed on May 19, 2023 has been accepted and entered by the office. The disclosure is objected to because of the following informalities: (1) since case 16/631,937 has been patented, applicant is required to update this information in the first paragraph of the specification; (2) Figure 4B contains two nucleotide sequences having more than 10 nucleotides. However, Brief Description Of The Drawing related to Figure 4B only describes one nucleotide sequence (SEQ ID NO:8); and (3) Figure 10 contains 16 nucleotide sequences having more than 10 nucleotides. However, Brief Description Of The Drawing related to Figure 16 only describes three nucleotide sequences (SEQ ID NOs:18 to 20). Appropriate correction is required. Claim Rejections - 35 USC § 102 The following is a quotation of the appropriate paragraphs of 35 U.S.C. 102 that form the basis for the rejections under this section made in this Office action: A person shall be entitled to a patent unless – (a)(1) the claimed invention was patented, described in a printed publication, or in public use, on sale, or otherwise available to the public before the effective filing date of the claimed invention. Claims 1, 2, 4, and 7-9 are rejected under 35 U.S.C. 102 (a) (1) as being anticipated by Bao et al., (US 2003/0129611 A1, published on July 10, 2003). Regarding claims 1, 2, 4, and 7-9, Bao et al., teach a method for detecting a target nucleic acid sequence, comprising the steps: providing a nucleic acid sample from a subject (eg., target WT having SEQ ID No:19 in Table 3); detecting the target nucleic acid sequence using a detection probe (eg., shared-stem probe 19/stem7 having SEQ ID No:15 in Table 3), wherein the detection probe comprises a DNA fingerloop stem loop structure; wherein the DNA fingerloop stem loop structure comprises an antisense region that binds to the target nucleic acid sequence; wherein the antisense region is located in a loop and in one strand of the stem loop of the DNA fingerloop stem loop structure; wherein the DNA fingerloop stem loop structure diminishes base pairing to a mismatched target nucleic acid (eg., by enhancing specificity); and wherein the stem loop has a stem region of about 7 to about 20 base-pairs as recited in claim 1 wherein the DNA fingerloop stem loop structure provides increased detection specificity of the target nucleic acid sequence (ie., by enhancing specificity) as recited in claim 2, the detection probe is capable of hybridizing to an RNA target molecule as recited in claim 4, the one strand of the stem loop is an ascending strand of the stem loop (ie., a stem of a molecular beacon probe that moves outward from the 5’ end toward the loop) as recited in claim 7, the antisense region that binds to the target nucleic acid sequence comprises from about 10 to about 35 nucleotides (eg., 20 nucleotides, see SEQ ID No:15 in Table 3) as recited in claim 8, and the DNA fingerloop stem loop structure that binds to the target nucleic acid sequence comprises from about 25 to about 60 nucleotides (eg., 27 nucleotides, see SEQ ID No:19 in Table 3) as recited in claim 9 (see paragraphs [0016], [0017], [0026], [0027], [0034], [0050], [0057], [0059], [0170], [0185], and [0190], Table 3, and Figures 1, 2, 11, 12, and 19). Therefore, Bao et al., teach all limitations recited in claims 1, 2, 4, and 7-9. Conclusion No claim is allowed. Any inquiry concerning this communication or earlier communications from the examiner should be directed to Frank Lu, Ph. D., whose telephone number is (571)272-0746. The examiner can normally be reached Monday to Friday, 9 AM to 5 PM. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/ interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Anne Gussow, Ph.D., can be reached at 571-272-6047. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /FRANK W LU/ Primary Examiner, Art Unit 1683 September 4, 2026
Read full office action

Prosecution Timeline

Dec 20, 2022
Application Filed
Sep 10, 2026
Non-Final Rejection mailed — §102 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12735736
MARINE DNA POLYMERASE I
4y 5m to grant Granted Sep 15, 2026
Patent 12735712
ELECTROCHEMICAL DETECTION NANOSTRUCTURE, SYSTEMS AND USES THEREOF
3y 7m to grant Granted Sep 15, 2026
Patent 12703878
CLOSED LINEAR DNA PRODUCTION
3y 10m to grant Granted Aug 11, 2026
Patent 12698526
DNA Detection Method and Device Therefor
8y 5m to grant Granted Aug 04, 2026
Patent 12678792
METHODS FOR CONDUCTING MULTIPLEXED ASSAYS
4y 10m to grant Granted Jul 14, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

1-2
Expected OA Rounds
63%
Grant Probability
99%
With Interview (+67.7%)
4y 1m (~4m remaining)
Median Time to Grant
Low
PTA Risk
Based on 711 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month